• / Free eNewsletters & Magazine
  • / My Account
Home>A Pharmaceutical Manufacturer Approached Quantzig to Help Them with Real-World Evidence Analytics and Design Better Treatment Options

A Pharmaceutical Manufacturer Approached Quantzig to Help Them with Real-World Evidence Analytics and Design Better Treatment Options

A Pharmaceutical Manufacturer Approached Quantzig to Help Them with Real-World Evidence Analytics and Design Better Treatment Options

10/06/2017

A Pharmaceutical Manufacturer Approached Quantzig to Help Them with Real-World Evidence Analytics and Design Better Treatment Options

Quantzig, a global analytics solutions provider, has announced the completion of their latest real-world evidence analytics study on the pharmaceutical manufacturing industry. The client, a leading pharmaceutical manufacturer, wanted to track the market share and update reports based on changing stakeholder requirements. The client wanted to track future growth opportunities and augment their market shares.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171006005038/en/

Market Tracking and Real World Product Performance Analysis. (Graphic: Business Wire)

Market Tracking and Real World Product Performance Analysis. (Graphic: Business Wire)

According to the analytics experts at Quantzig, “Real-world evidence analytics helps pharmaceutical manufacturing companies to respond to the ever-changing market dynamics and compete with the major players to drive patient value.”

Globally, the pharmaceutical industry is rapidly transforming, and key players are identifying new approaches to uncover and better define the unmet needs of the customers. Organizations are adopting real-world evidence analytics to gain actionable insights into the treatment landscape. They are also gaining insights into the untapped opportunities and increasing market shares.

Request a free demo to see how Quantzig’s solutions can help you.

The solution offered by Quantzig helped the client to assess drug performance across numerous dimensions like market share, drug sales performance, and duration of therapy. The client was able to speed the development of new treatments and provide better options to customers to stay ahead in the market.

©2017 Morningstar Advisor. All right reserved.